"The comparative analyses of a plan's nonquantitative treatment limitations are statutorily required under the MHPAEA, so plan fiduciaries should continue to prepare comparative analyses, keep them updated, and be ready to provide them upon request by regulators and participants. Plan fiduciaries should continue to ensure nonquantitative treatment limitations are applied no more restrictively for MH/SUD benefits than for M/S benefits in the same classification."  MORE >>